Conditions: Schizophrenia
Keywords: Schizophrenia Mental Disorders Psychotic Disorders Antipsychotic Cognitive testing
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 97
Healthy volunteers: no

Brief summary:
The purpose of this study is to explore changes in efficacy, cognitive functioning, and safety of flexibly-dosed Brexpiprazole monotherapy in subjects with acute schizophrenia

Detailed description:

Arms:
arm 1: Treatment (6 weeks) Up to 4 mg/day, once daily dose, tablets, orally arm 2: Aripiprazole - Up to 20 mg/day, once daily dose, tablets, orally

Interventions: intervention 1: Brexpiprazole intervention 2: Aripiprazole
Intervention descriptions: intervention 1: Treatment (6 weeks) Up to 4 mg/day, once daily dose, tablets, orally intervention 2: Up to 20 mg/day, once daily dose, tablets, orally

Protocol document: